NDC11 82347050504

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDC	Product root
82347-0505-04	82347-0505
82347-0505-4	82347-0505
82347-505-04	82347-505

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Relivyx Plus	LIDOCAINE	V2 Pharma LLC	08aeb3f5-56ea-4fd7-b151-e6dc65f202da	2026-04-16	Warnings, Adverse reactions	Exact identifier ndc (package): 82347-0505-4 ndc11 (package): 82347050504
Lidocaine 5%	LIDOCAINE 5%	YARAL Pharma Inc.	fc495fc8-15d6-27c7-e053-6394a90ab30d	2026-03-24	Warnings, Adverse reactions	Exact identifier ndc (package): 82347-0505-4 ndc (product): 82347-0505 ndc11 (package): 82347050504

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.